Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
|
+$465M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$268M |
| 3 |
Verizon
VZ
|
+$239M |
| 4 |
Microsoft
MSFT
|
+$212M |
| 5 |
Apple
AAPL
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$421M |
| 2 |
Becton Dickinson
BDX
|
+$213M |
| 3 |
Home Depot
HD
|
+$191M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$132M |
| 5 |
Broadcom
AVGO
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.96% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.98% |
| 4 | Consumer Discretionary | 10.85% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2851
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.4B
| $1.18M | ﹤0.01% |
37,925
+170
| +0.5% | +$5.28K |
|
2852
First Watch Restaurant Group
FWRG
$792M
| $1.17M | ﹤0.01% |
+69,720
| New | +$1.39M |
|
2853
Luxfer Holdings
LXFR
$456M
| $1.17M | ﹤0.01% |
60,434
+1,649
| +3% | +$33.6K |
|
|
AMNB
2854
DELISTED
American National Bankshares Inc
AMNB
| $1.17M | ﹤0.01% |
30,923
+120
| +0.4% | +$4.44K |
|
2855
Foghorn Therapeutics
FHTX
$266M
| $1.16M | ﹤0.01% |
50,811
+853
| +2% | +$12.3K |
|
2856
GCM Grosvenor
GCMG
$754M
| $1.16M | ﹤0.01% |
110,680
+5,945
| +6% | +$66.4K |
|
2857
Mid Penn Bancorp
MPB
$971M
| $1.15M | ﹤0.01% |
36,235
+11,856
| +49% | +$352K |
|
|
IDEX
2858
DELISTED
Ideanomics, Inc. Common Stock
IDEX
| $1.14M | ﹤0.01% |
7,618
+483
| +7% | +$103K |
|
|
EGIO
2859
DELISTED
Edgio, Inc. Common Stock
EGIO
| $1.13M | ﹤0.01% |
8,262
+372
| +5% | +$44.2K |
|
2860
Allient
ALNT
$1.49B
| $1.13M | ﹤0.01% |
30,925
+942
| +3% | +$34.8K |
|
2861
Preformed Line Products
PLPC
$1.75B
| $1.13M | ﹤0.01% |
17,448
| – | – |
|
2862
First Internet Bancorp
INBK
$257M
| $1.13M | ﹤0.01% |
23,913
+751
| +3% | +$30.4K |
|
|
EBTC
2863
DELISTED
Enterprise Bancorp
EBTC
| $1.12M | ﹤0.01% |
24,995
+720
| +3% | +$28.5K |
|
|
RYZ
2864
Ryerson Holding Corp
RYZ
$1.44B
| $1.12M | ﹤0.01% |
42,941
| – | – |
|
2865
CNB Financial Corp
CCNE
$1.04B
| $1.12M | ﹤0.01% |
42,134
+1,296
| +3% | +$34K |
|
2866
Tyra Biosciences
TYRA
$1.9B
| $1.12M | ﹤0.01% |
+79,347
| New | +$1.58M |
|
2867
Tidewater
TDW
$3.73B
| $1.11M | ﹤0.01% |
104,100
+102
| +0.1% | +$1.2K |
|
|
DADA
2868
DELISTED
Dada Nexus
DADA
| $1.11M | ﹤0.01% |
84,636
+1,410
| +2% | +$27.2K |
|
2869
Evolus
EOLS
$385M
| $1.11M | ﹤0.01% |
170,965
| – | – |
|
2870
MVB Financial
MVBF
$397M
| $1.11M | ﹤0.01% |
26,796
+826
| +3% | +$34.9K |
|
|
MRNS
2871
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $1.1M | ﹤0.01% |
92,766
| – | – |
|
|
LONA
2872
LeonaBio Inc
LONA
$66.3M
| $1.1M | ﹤0.01% |
8,455
+278
| +3% | +$35.2K |
|
2873
Entrada Therapeutics
TRDA
$264M
| $1.1M | ﹤0.01% |
+64,019
| New | +$1.55M |
|
|
TCRR
2874
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $1.1M | ﹤0.01% |
235,253
+3,202
| +1% | +$20K |
|
|
CSTR
2875
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $1.09M | ﹤0.01% |
52,028
+1,456
| +3% | +$31.3K |
|
Similar funds
Charles Schwab's Q4 2021 Portfolio in Review
As of Q4 2021, Charles Schwab held 3,647 positions worth $339B, up 11% from $306B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Charles Schwab's Q4 2021 filing shows 148 new, 2,572 increased, 501 reduced and 58 closed positions. Its largest new stake was Kyndryl: 2,951,149 shares worth $53.4M. The largest sale was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, an estimated $421M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2021 buy was Kyndryl: 2,951,149 shares worth $53.4M.
- Charles Schwab added most to State Street SPDR Portfolio Short Term Treasury ETF in Q4 2021, an estimated $465M increase.
- Charles Schwab's biggest Q4 2021 reduction was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, cutting an estimated $421M.
- Charles Schwab fully exited Kansas City Southern in Q4 2021, selling an estimated $113M.
- Charles Schwab's ten largest holdings make up 18% of its $339B portfolio in Q4 2021.
- Charles Schwab opened 148 new positions and closed 58 in Q4 2021.
- Charles Schwab's portfolio value rose 11% quarter-over-quarter to $339B.
Based on Charles Schwab's 13F filing for Q4 2021, filed 11 Feb 2022.